img

Global Edible Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Edible Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Edible Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Inactivated Vaccines accounting for % of the Edible Vaccine global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Medical Care segment is altered to an % CAGR throughout this forecast period.
The global key companies of Edible Vaccine include GSK, Sanofi, Merck, Merial, Santa Cruz Animal Health and Ceva, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
The United States Edible Vaccine market size was US$ million in 2024, while China size was US$ million. The proportion of the United States was % in 2024, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Edible Vaccine landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Edible Vaccine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Edible Vaccine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Edible Vaccine market. Readers of the report can become informed about current and future trends of the global Edible Vaccine market and how they will impact market growth during the forecast period.



By Company


GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva
Segment by Type
Inactivated Vaccines
Others

Segment by Application


Medical Care
Livestock
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Edible Vaccine in global and regional level.
Chapter 3Detailed analysis of Edible Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Edible Vaccine revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Edible Vaccine Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Inactivated Vaccines
1.2.3 Others
1.3 Market by Application
1.3.1 Global Edible Vaccine Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Medical Care
1.3.3 Livestock
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Edible Vaccine Market Size (2018-2034)
2.2 Edible Vaccine Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Edible Vaccine Market Size by Region (2018-2023)
2.4 Global Edible Vaccine Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Edible Vaccine Countries Ranking by Market Size
3 Edible Vaccine Competitive by Company
3.1 Global Edible Vaccine Revenue by Players
3.1.1 Global Edible Vaccine Revenue by Players (2018-2023)
3.1.2 Global Edible Vaccine Market Share by Players (2018-2023)
3.2 Global Edible Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Edible Vaccine Revenue
3.4 Global Edible Vaccine Market Concentration Ratio
3.4.1 Global Edible Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Edible Vaccine Revenue in 2024
3.5 Global Key Players of Edible Vaccine Head office and Area Served
3.6 Global Key Players of Edible Vaccine, Product and Application
3.7 Global Key Players of Edible Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Edible Vaccine Breakdown Data by Type
4.1 Global Edible Vaccine Historic Revenue by Type (2018-2023)
4.2 Global Edible Vaccine Forecasted Revenue by Type (2024-2034)
5 Global Edible Vaccine Breakdown Data by Application
5.1 Global Edible Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Edible Vaccine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Edible Vaccine Revenue by Company (2021-2023)
6.2 North America Edible Vaccine Revenue by Type (2018-2034)
6.3 North America Edible Vaccine Revenue by Application (2018-2034)
6.4 North America Edible Vaccine Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Edible Vaccine Revenue by Company (2021-2023)
7.2 Europe Edible Vaccine Revenue by Type (2018-2034)
7.3 Europe Edible Vaccine Revenue by Application (2018-2034)
7.4 Europe Edible Vaccine Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Edible Vaccine Revenue by Company (2021-2023)
8.2 Asia Pacific Edible Vaccine Revenue by Type (2018-2034)
8.3 Asia Pacific Edible Vaccine Revenue by Application (2018-2034)
8.4 Asia Pacific Edible Vaccine Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Edible Vaccine Revenue by Company (2021-2023)
9.2 Latin America Edible Vaccine Revenue by Type (2018-2034)
9.3 Latin America Edible Vaccine Revenue by Application (2018-2034)
9.4 Latin America Edible Vaccine Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Edible Vaccine Revenue by Company (2021-2023)
10.2 Middle East and Africa Edible Vaccine Revenue by Type (2018-2034)
10.3 Middle East and Africa Edible Vaccine Revenue by Application (2018-2034)
10.4 Middle East and Africa Edible Vaccine Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Edible Vaccine Products and Services
11.1.4 GSK Edible Vaccine Revenue in Edible Vaccine Business (2018-2023)
11.1.5 GSK Edible Vaccine SWOT Analysis
11.1.6 GSK Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Edible Vaccine Products and Services
11.2.4 Sanofi Edible Vaccine Revenue in Edible Vaccine Business (2018-2023)
11.2.5 Sanofi Edible Vaccine SWOT Analysis
11.2.6 Sanofi Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Edible Vaccine Products and Services
11.3.4 Merck Edible Vaccine Revenue in Edible Vaccine Business (2018-2023)
11.3.5 Merck Edible Vaccine SWOT Analysis
11.3.6 Merck Recent Development
11.4 Merial
11.4.1 Merial Company Details
11.4.2 Merial Business Overview
11.4.3 Merial Edible Vaccine Products and Services
11.4.4 Merial Edible Vaccine Revenue in Edible Vaccine Business (2018-2023)
11.4.5 Merial Edible Vaccine SWOT Analysis
11.4.6 Merial Recent Development
11.5 Santa Cruz Animal Health
11.5.1 Santa Cruz Animal Health Company Details
11.5.2 Santa Cruz Animal Health Business Overview
11.5.3 Santa Cruz Animal Health Edible Vaccine Products and Services
11.5.4 Santa Cruz Animal Health Edible Vaccine Revenue in Edible Vaccine Business (2018-2023)
11.5.5 Santa Cruz Animal Health Edible Vaccine SWOT Analysis
11.5.6 Santa Cruz Animal Health Recent Development
11.6 Ceva
11.6.1 Ceva Company Details
11.6.2 Ceva Business Overview
11.6.3 Ceva Edible Vaccine Products and Services
11.6.4 Ceva Edible Vaccine Revenue in Edible Vaccine Business (2018-2023)
11.6.5 Ceva Edible Vaccine SWOT Analysis
11.6.6 Ceva Recent Development
12 Edible Vaccine Market Dynamics
12.1 Edible Vaccine Industry Trends
12.2 Edible Vaccine Market Drivers
12.3 Edible Vaccine Market Challenges
12.4 Edible Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Edible Vaccine Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of Inactivated Vaccines
Table 3. Key Players of Others
Table 4. Global Edible Vaccine Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 5. Global Edible Vaccine Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 6. Global Edible Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Edible Vaccine Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 8. Global Edible Vaccine Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 9. Global Edible Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 10. Global Edible Vaccine Market Share by Players (2018-2023)
Table 11. Global Top Edible Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edible Vaccine as of 2024)
Table 12. Ranking of Global Top Edible Vaccine Companies by Revenue (US$ Million) in 2024
Table 13. Global 5 Largest Players Market Share by Edible Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 14. Global Key Players of Edible Vaccine, Headquarters and Area Served
Table 15. Global Key Players of Edible Vaccine, Product and Application
Table 16. Global Key Players of Edible Vaccine, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Edible Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 19. Global Edible Vaccine Revenue Market Share by Type (2018-2023)
Table 20. Global Edible Vaccine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 21. Global Edible Vaccine Revenue Market Share by Type (2024-2034)
Table 22. Global Edible Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Edible Vaccine Revenue Market Share by Application (2018-2023)
Table 24. Global Edible Vaccine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Edible Vaccine Revenue Market Share by Application (2024-2034)
Table 26. North America Edible Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 27. North America Edible Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 28. North America Edible Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 29. North America Edible Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 30. North America Edible Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 31. North America Edible Vaccine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Edible Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 33. North America Edible Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 34. Europe Edible Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 35. Europe Edible Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 36. Europe Edible Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 37. Europe Edible Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 38. Europe Edible Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 39. Europe Edible Vaccine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 40. Europe Edible Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 41. Europe Edible Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 42. Asia Pacific Edible Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 43. Asia Pacific Edible Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 44. Asia Pacific Edible Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 45. Asia Pacific Edible Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 46. Asia Pacific Edible Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 47. Asia-Pacific Edible Vaccine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 48. Asia Pacific Edible Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 49. Asia Pacific Edible Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 50. Latin America Edible Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 51. Latin America Edible Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 52. Latin America Edible Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 53. Latin America Edible Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 54. Latin America Edible Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 55. Latin America Edible Vaccine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 56. Latin America Edible Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 57. Latin America Edible Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 58. Middle East and Africa Edible Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 59. Middle East and Africa Edible Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 60. Middle East and Africa Edible Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 61. Middle East and Africa Edible Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Edible Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 63. Middle East and Africa Edible Vaccine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 64. Middle East and Africa Edible Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Edible Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Edible Vaccine Product and Services
Table 69. GSK Edible Vaccine Revenue in Edible Vaccine Business (2018-2023) & (US$ Million)
Table 70. GSK Edible Vaccine SWOT Analysis
Table 71. GSK Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Edible Vaccine Product and Services
Table 75. Sanofi Edible Vaccine Revenue in Edible Vaccine Business (2018-2023) & (US$ Million)
Table 76. Sanofi Edible Vaccine SWOT Analysis
Table 77. Sanofi Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Edible Vaccine Product and Services
Table 81. Merck Edible Vaccine Revenue in Edible Vaccine Business (2018-2023) & (US$ Million)
Table 82. Merck Edible Vaccine SWOT Analysis
Table 83. Merck Recent Development
Table 84. Merial Company Details
Table 85. Merial Business Overview
Table 86. Merial Edible Vaccine Product and Services
Table 87. Merial Edible Vaccine Revenue in Edible Vaccine Business (2018-2023) & (US$ Million)
Table 88. Merial Edible Vaccine SWOT Analysis
Table 89. Merial Recent Development
Table 90. Santa Cruz Animal Health Company Details
Table 91. Santa Cruz Animal Health Business Overview
Table 92. Santa Cruz Animal Health Edible Vaccine Product and Services
Table 93. Santa Cruz Animal Health Edible Vaccine Revenue in Edible Vaccine Business (2018-2023) & (US$ Million)
Table 94. Santa Cruz Animal Health Edible Vaccine SWOT Analysis
Table 95. Santa Cruz Animal Health Recent Development
Table 96. Ceva Company Details
Table 97. Ceva Business Overview
Table 98. Ceva Edible Vaccine Product and Services
Table 99. Ceva Edible Vaccine Revenue in Edible Vaccine Business (2018-2023) & (US$ Million)
Table 100. Ceva Edible Vaccine SWOT Analysis
Table 101. Ceva Recent Development
Table 102. Edible Vaccine Market Trends
Table 103. Edible Vaccine Market Drivers
Table 104. Edible Vaccine Market Challenges
Table 105. Edible Vaccine Market Restraints
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Edible Vaccine Product Picture
Figure 2. Global Edible Vaccine Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Edible Vaccine Market Share by Type: 2024 VS 2034
Figure 4. Inactivated Vaccines Features
Figure 5. Others Features
Figure 6. Global Edible Vaccine Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 7. Global Edible Vaccine Market Share by Application: 2024 VS 2034
Figure 8. Medical Care
Figure 9. Livestock
Figure 10. Others
Figure 11. Edible Vaccine Report Years Considered
Figure 12. Global Edible Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Edible Vaccine Market Size 2018-2034 (US$ Million)
Figure 14. Global Edible Vaccine Market Size Market Share by Region: 2024 VS 2034
Figure 15. Global Edible Vaccine Revenue Market Share by Region in 2018 VS 2024
Figure 16. Global Edible Vaccine Revenue Market Share Forecast by Region (2024-2034)
Figure 17. Global Top 10 Edible Vaccine Countries Ranking by Market Size (US$ Million) in 2024
Figure 18. Global Edible Vaccine Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 19. Global Edible Vaccine Market Share by Players in 2024
Figure 20. Global Top Edible Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edible Vaccine as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Edible Vaccine Revenue in 2024
Figure 22. North America Edible Vaccine Revenue Market Share by Company in 2024
Figure 23. North America Edible Vaccine Revenue Market Share by Type (2018-2034)
Figure 24. North America Edible Vaccine Revenue Market Share by Application (2018-2034)
Figure 25. North America Edible Vaccine Revenue Share by Country (2018-2034)
Figure 26. U.S. Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 27. Canada Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 28. Europe Edible Vaccine Revenue Market Share by Company in 2024
Figure 29. Europe Edible Vaccine Revenue Market Share by Type (2018-2034)
Figure 30. Europe Edible Vaccine Revenue Market Share by Application (2018-2034)
Figure 31. Europe Edible Vaccine Revenue Share by Country (2018-2034)
Figure 32. Germany Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 33. France Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 34. U.K. Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 35. Italy Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 36. Russia Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Edible Vaccine Revenue Market Share by Company in 2024
Figure 38. Asia Pacific Edible Vaccine Revenue Market Share by Type (2018-2034)
Figure 39. Asia Pacific Edible Vaccine Revenue Market Share by Application (2018-2034)
Figure 40. Asia Pacific Edible Vaccine Revenue Share by Region (2018-2034)
Figure 41. China Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 42. Japan Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 43. South Korea Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 44. India Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 45. Australia Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 46. Taiwan Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 47. Indonesia Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 48. Thailand Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 49. Malaysia Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 50. Philippines Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 51. Vietnam Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 52. Latin America Edible Vaccine Revenue Market Share by Company in 2024
Figure 53. Latin America Edible Vaccine Revenue Market Share by Type (2018-2034)
Figure 54. Latin America Edible Vaccine Revenue Market Share by Application (2018-2034)
Figure 55. Latin America Edible Vaccine Revenue Share by Country (2018-2034)
Figure 56. Mexico Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. Brazil Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. Argentina Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 59. Middle East and Africa Edible Vaccine Revenue Market Share by Company in 2024
Figure 60. Middle East and Africa Edible Vaccine Revenue Market Share by Type (2018-2034)
Figure 61. Middle East and Africa Edible Vaccine Revenue Market Share by Application (2018-2034)
Figure 62. Middle East and Africa Edible Vaccine Revenue Share by Country (2018-2034)
Figure 63. Turkey Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 64. Saudi Arabia Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 65. U.A.E Edible Vaccine Revenue (2018-2034) & (US$ Million)
Figure 66. GSK Revenue Growth Rate in Edible Vaccine Business (2018-2023)
Figure 67. Sanofi Revenue Growth Rate in Edible Vaccine Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in Edible Vaccine Business (2018-2023)
Figure 69. Merial Revenue Growth Rate in Edible Vaccine Business (2018-2023)
Figure 70. Santa Cruz Animal Health Revenue Growth Rate in Edible Vaccine Business (2018-2023)
Figure 71. Ceva Revenue Growth Rate in Edible Vaccine Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed